Skip to main content
. 2022 Nov 17;2022(11):CD010216. doi: 10.1002/14651858.CD010216.pub7

NCT02398487.

Study name Head‐to‐head comparison of personal vaporizers versus cig‐a‐like: prospective 6‐month randomized control design study (VAPECIG 2)
Methods Randomized parallel‐assignment open‐label trial
Setting: Italy, community
Participants Estimated enrolment: 200
Inclusion criteria:
  • (People who smoke) in good general health

  • Committed to follow trial procedures


Exclude if:
  • Recent vaping history (stopped vaping < 3 months ago)

  • Use of any other form of non‐combustible nicotine‐containing products (chewable tobacco or nicotine replacement therapy)

  • Symptomatic cardiovascular disease

  • Clinical history of asthma and COPD

  • Regular psychotropic medication use

  • Current or past history of alcohol abuse

  • Use of smokeless tobacco or nicotine replacement therapy

  • Pregnancy or breastfeeding

Interventions Comparison between 2 types of EC; 'personal vaporizers' and 'cig‐a‐like'
Outcomes 24 weeks:
  • Smoking cessation

  • Smoking reduction

Starting date October 2014
Contact information Riccardo Polosa
Notes